Agilent Technologies Inc vs Ishares Msci Brazil ETF — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Ishares Msci Brazil ETF trades at $34.01. The key difference: Agilent Technologies Inc pays a 0.69% dividend while Ishares Msci Brazil ETF pays none, and Agilent Technologies Inc is trading nearer its 52-week high, Ishares Msci Brazil ETF nearer its low. Which is the better fit depends on your goals.
| A | EWZ | |
|---|---|---|
Market Cap | $42.00B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $157.20 | $41.75 |
52-Week Low | $110.24 | $27.36 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
EWZ trades at $35.34, down 1.31% today, with a bearish technical signal from moving averages. The ETF tracks Brazilian equities, facing headwinds from US tariffs and currency volatility. Recent institutional buying includes Empowered Funds' $3.06 million position (Defense World, Aug 5, 2026), while technical support sits at $34-$35.
Outlook hinges on Brazil's economic policies and commodity prices. Opportunities exist if rate cuts continue, but risks include political uncertainty and competitive pressure from lower-fee alternatives like FLBR. The dividend yield of approximately 3.78% provides income, but consistency is challenged by reliance on commodity-driven holdings.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Read more on EWZ →